Diversified Trust Co - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Diversified Trust Co ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$991
-99.9%
12,596
-0.6%
0.04%
-2.4%
Q3 2022$938,000
+24.1%
12,666
+9.2%
0.04%
+31.2%
Q2 2022$756,000
+3.0%
11,595
-0.2%
0.03%
+23.1%
Q1 2022$734,000
+16.9%
11,615
-1.9%
0.03%
+23.8%
Q4 2021$628,000
-19.7%
11,837
+6.8%
0.02%
-25.0%
Q3 2021$782,000
+6.0%
11,081
+0.1%
0.03%
+3.7%
Q2 2021$738,000
+40.3%
11,073
-11.2%
0.03%
-50.0%
Q4 2013$526,000
+19.0%
12,475
+12.6%
0.05%
+14.9%
Q3 2013$442,00011,0750.05%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders